{"id":1392,"date":"2025-09-15T12:37:21","date_gmt":"2025-09-15T12:37:21","guid":{"rendered":"https:\/\/medi-pharm.sk\/prispevok-20"},"modified":"2025-11-23T15:30:15","modified_gmt":"2025-11-23T15:30:15","slug":"prispevok-20","status":"publish","type":"post","link":"https:\/\/medi-pharm.sk\/sk\/prispevok-20","title":{"rendered":"Nukleozidov\u00e9 a nukleotidov\u00e9 anal\u00f3gy: ch\u00e9mia, v\u00fdroba a CMC strat\u00e9gie pre regula\u010dn\u00e9 podanie"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"1392\" class=\"elementor elementor-1392 elementor-761\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2db5f659 e-flex e-con-boxed e-con e-parent\" data-id=\"2db5f659\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-77bc2cf6 elementor-widget elementor-widget-spacer\" data-id=\"77bc2cf6\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-25c20a2e elementor-widget elementor-widget-theme-post-title elementor-page-title elementor-widget-heading\" data-id=\"25c20a2e\" data-element_type=\"widget\" data-widget_type=\"theme-post-title.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Nukleozidov\u00e9 a nukleotidov\u00e9 anal\u00f3gy: ch\u00e9mia, v\u00fdroba a CMC strat\u00e9gie pre regula\u010dn\u00e9 podanie<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-886b17a elementor-widget elementor-widget-spacer\" data-id=\"886b17a\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2790e079 elementor-widget elementor-widget-text-editor\" data-id=\"2790e079\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>Vedeck\u00e9 pozadie a terapeutick\u00fd kontext<\/h3><p>Nukleozidy, pozost\u00e1vaj\u00face z dus\u00edkatej b\u00e1zy kovalentne viazanej na rib\u00f3zu alebo deoxyrib\u00f3zu, s\u00fa z\u00e1kladn\u00fdmi prekurzormi pre biosynt\u00e9zu nukleov\u00fdch kysel\u00edn a tvoria chemick\u00e9 jadro oligonukleotidov\u00fdch monom\u00e9rov pou\u017e\u00edvan\u00fdch pri synt\u00e9ze na pevnej f\u00e1ze. Chemicky vyr\u00e1ban\u00e9 DNA fosforamidity typicky obsahuj\u00fa chr\u00e1nen\u00fa 5\u2032\u2011hydroxylov\u00fa skupinu (5\u2032\u2011DMT) a 3\u2032\u2011fosforamidit nes\u00faci kyanoetylov\u00e9 a diizopropylam\u00ednov\u00e9 \u010dasti, zatia\u013e \u010do RNA monom\u00e9ry vy\u017eaduj\u00fa dodato\u010dn\u00fa 2\u2032\u2011OH ochranu, aby sa predi\u0161lo ved\u013eaj\u0161\u00edm reakci\u00e1m po\u010das zostavovania. Okrem kanonick\u00fdch stavebn\u00fdch blokov biologick\u00e9 syst\u00e9my vyu\u017e\u00edvaj\u00fa \u0161irok\u00fd reperto\u00e1r prirodzene modifikovan\u00fdch nukleozidov \u2013 inoz\u00edn, N6\u2011metyladenoz\u00edn, pseudourid\u00edn a 2\u2011tiourid\u00edn medzi nimi \u2013 ktor\u00e9 moduluj\u00fa transl\u00e1ciu, stabilitu RNA a g\u00e9nov\u00fa expresiu. Syntetick\u00e9 za\u010dlenenie modifikovan\u00fdch nukleozidov vyu\u017e\u00edva \u0161truktur\u00e1lnu mimikry na naru\u0161enie metabolizmu nukleov\u00fdch kysel\u00edn: po intracelul\u00e1rnej fosforyl\u00e1cii s\u00fa mnoh\u00e9 anal\u00f3gy rozpoznan\u00e9 hostite\u013esk\u00fdmi alebo v\u00edrusov\u00fdmi enz\u00fdmami a uplat\u0148uj\u00fa svoje \u00fa\u010dinky bu\u010f kompetit\u00edvnou inhib\u00edciou enz\u00fdmov, ako s\u00fa polymer\u00e1zy, ribonukleotid redukt\u00e1za a nukleozid fosforyl\u00e1zy, alebo p\u00f4soben\u00edm ako termin\u00e1tory re\u0165azca po za\u010dlenen\u00ed do vl\u00e1kien nukleov\u00fdch kysel\u00edn. Tieto mechanistick\u00e9 dr\u00e1hy s\u00fa z\u00e1kladom rozsiahleho klinick\u00e9ho vyu\u017eitia nukleozidov\u00fdch a nukleotidov\u00fdch anal\u00f3gov v onkol\u00f3gii a antiv\u00edrusovej terapii.    <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0b7d1cb elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"0b7d1cb\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-41eb9c14 elementor-widget elementor-widget-spacer\" data-id=\"41eb9c14\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a76ef61 elementor-widget elementor-widget-text-editor\" data-id=\"a76ef61\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>Historick\u00e1 perspekt\u00edva a pr\u00edkladn\u00e1 zl\u00fa\u010denina<\/h3><p>Terapeutick\u00e9 vyu\u017eitie nukleozidov\u00fdch anal\u00f3gov siaha do onkol\u00f3gie polovice 20. storo\u010dia, kde antimetabolity ako 6\u2011merkaptopur\u00edn a cytarab\u00edn stanovili paradigmu metabolickej interferencie v r\u00fdchlo sa deliacich bunk\u00e1ch. Po\u010das nasleduj\u00facich desa\u0165ro\u010d\u00ed sa t\u00e1to trieda diverzifikovala na onkologick\u00e9 antimetabolity, antiv\u00edrusov\u00e9 nukleozidy a nukleotidov\u00e9 prodrugs s vylep\u0161en\u00fdmi farmakokinetick\u00fdmi vlastnos\u0165ami. Acyklovir je pr\u00edkladom transla\u010dn\u00e9ho \u00faspechu strat\u00e9gi\u00ed selekt\u00edvnej aktiv\u00e1cie: ako acyklick\u00fd guanoz\u00ednov\u00fd anal\u00f3g je prednostne fosforylovan\u00fd v\u00edrusovou tymid\u00ednkin\u00e1zou na monofosf\u00e1t a n\u00e1sledne hostite\u013esk\u00fdmi kin\u00e1zami na akt\u00edvny trifosf\u00e1t, ktor\u00fd s\u00fa\u0165a\u017e\u00ed s dGTP pri v\u00edrusovej DNA polymer\u00e1ze a indukuje termin\u00e1ciu re\u0165azca. T\u00e1to selekt\u00edvna aktiv\u00e1cia prodrugov poskytuje priazniv\u00fd terapeutick\u00fd index pri infekci\u00e1ch herpes a varicella\u2011zoster a stanovila mechanistick\u00fa \u0161abl\u00f3nu pre neskor\u0161ie guanoz\u00ednov\u00e9 anal\u00f3gy a prodrugs.   <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-01e8e83 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"01e8e83\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4feb5b5 elementor-widget elementor-widget-text-editor\" data-id=\"4feb5b5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>V\u00fdrobn\u00e9 v\u00fdzvy a s\u00fa\u010dasn\u00e9 rie\u0161enia<\/h3><p>Z h\u013eadiska v\u00fdroby predstavuj\u00fa nukleozidov\u00e9 anal\u00f3gy viacero vz\u00e1jomne z\u00e1visl\u00fdch v\u00fdziev, ktor\u00e9 zah\u0155\u0148aj\u00fa stereochemick\u00fa kontrolu, regioselektivitu, polymorfizmus a environment\u00e1lne aspekty. Glykozyla\u010dn\u00e9 kroky vy\u017eaduj\u00fa presn\u00fa kontrolu stereocentier a regiochemie, tradi\u010dne dosahovan\u00fa prostredn\u00edctvom strat\u00e9gi\u00ed ochrann\u00fdch skup\u00edn a viacstup\u0148ov\u00fdch sekvenci\u00ed, ktor\u00e9 zni\u017euj\u00fa celkov\u00fd v\u00fd\u0165a\u017eok a predl\u017euj\u00fa \u010dasy cyklov. N\u00e1sledne, polymorfn\u00e1 variabilita a distrib\u00facia ve\u013ekosti \u010dast\u00edc m\u00f4\u017eu v\u00fdrazne ovplyvni\u0165 rozp\u00fa\u0161\u0165anie a biologick\u00fa dostupnos\u0165, \u010do si vy\u017eaduje pr\u00edsnu kontrolu kry\u0161taliz\u00e1cie a in\u017einierstvo \u010dast\u00edc. S\u00fa\u010dasn\u00e9 v\u00fdrobn\u00e9 strat\u00e9gie \u010doraz viac zah\u0155\u0148aj\u00fa chemoenzymatick\u00e9 a biokatalytick\u00e9 transform\u00e1cie na rie\u0161enie t\u00fdchto obmedzen\u00ed: nukleozidov\u00e9 fosforyl\u00e1zy, kin\u00e1zy a transfer\u00e1zy umo\u017e\u0148uj\u00fa vysoko selekt\u00edvne transform\u00e1cie v miernych, vodn\u00fdch podmienkach, \u010d\u00edm zlep\u0161uj\u00fa regio\u2011 a stereoselektivitu, zvy\u0161uj\u00fa v\u00fd\u0165a\u017eky a zni\u017euj\u00fa pou\u017e\u00edvanie nebezpe\u010dn\u00fdch \u010dinidiel a odpad. Intenzifik\u00e1cia procesov a teleskopick\u00e9 sekvencie \u010falej zni\u017euj\u00fa manipul\u00e1ciu s medziproduktmi a spotrebu rozp\u00fa\u0161\u0165adiel, zatia\u013e \u010do pokro\u010dil\u00e9 kry\u0161taliza\u010dn\u00e9 techniky a met\u00f3dy in\u017einierstva \u010dast\u00edc zabezpe\u010duj\u00fa konzistentn\u00e9 vlastnosti pevnej f\u00e1zy. Prijatie princ\u00edpov zelenej ch\u00e9mie \u2013 v\u00fdber rozp\u00fa\u0161\u0165adiel, recykl\u00e1cia a minimalizovan\u00fd prebytok \u010dinidiel \u2013 prispieva k zlep\u0161eniu udr\u017eate\u013enosti bez kompromisov v kvalite produktu.     <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-178a4cc elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"178a4cc\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-380ec46 elementor-widget elementor-widget-text-editor\" data-id=\"380ec46\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>CMC, analytick\u00e1 strat\u00e9gia a regula\u010dn\u00e9 o\u010dak\u00e1vania<\/h3><p>Robustn\u00e1 CMC strat\u00e9gia pre nukleozidov\u00e9 a nukleotidov\u00e9 anal\u00f3gy integruje ortogon\u00e1lne analytick\u00e9 platformy, testy indikuj\u00face stabilitu a jasne od\u00f4vodnen\u00fd r\u00e1mec kontroly ne\u010dist\u00f4t. Kontrola testu a s\u00favisiacich l\u00e1tok sa typicky vykon\u00e1va pomocou HPLC\/UPLC podporovanej hmotnostnou spektrometriou pre potvrdenie hmotnosti a \u0161truktur\u00e1lne priradenie ne\u010dist\u00f4t, zatia\u013e \u010do charakteriz\u00e1cia pevnej f\u00e1zy (XRPD, DSC) a anal\u00fdza ve\u013ekosti \u010dast\u00edc sa pou\u017e\u00edvaj\u00fa na definovanie polymorfn\u00fdch a fyzik\u00e1lnych atrib\u00fatov, ktor\u00e9 ovplyv\u0148uj\u00fa v\u00fdkon. \u0160t\u00fadie n\u00fatenej degrad\u00e1cie s\u00fa nevyhnutn\u00e9 na definovanie degrada\u010dn\u00fdch dr\u00e1h a na stanovenie met\u00f3d indikuj\u00facich stabilitu; kvalifik\u00e1cia ne\u010dist\u00f4t mus\u00ed dodr\u017eiava\u0165 pr\u00edstup zalo\u017een\u00fd na riziku v s\u00falade s princ\u00edpmi ICH Q3 a region\u00e1lne \u0161pecifick\u00fdmi usmerneniami, s toxikologick\u00fdm od\u00f4vodnen\u00edm pre prahov\u00e9 hodnoty. Z procesn\u00e9ho h\u013eadiska s\u00fa na podporu regula\u010dn\u00fdch podan\u00ed potrebn\u00e9 validovan\u00e9 v\u00fdrobn\u00e9 a \u010distiace postupy, monitorovanie prostredia pre steriln\u00e9 alebo aseptick\u00e9 oper\u00e1cie a pr\u00edsna kvalifik\u00e1cia dod\u00e1vate\u013eov pre kritick\u00e9 medziprodukty a enzymatick\u00e9 vstupy. V\u00fdber formul\u00e1cie by mal by\u0165 riaden\u00fd profilom cie\u013eov\u00e9ho produktu a klinickou cestou podania, s oh\u013eadom na prodrug strat\u00e9gie, pevn\u00e9 disperzie, lipidov\u00e9 nosi\u010de alebo lyofilizovan\u00e9 prezent\u00e1cie na optimaliz\u00e1ciu biologickej dostupnosti a stability.    <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-14b4d6b elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"14b4d6b\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-faffdc4 elementor-widget elementor-widget-text-editor\" data-id=\"faffdc4\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>V\u00fdvojov\u00e9 a v\u00fdrobn\u00e9 kapacity (Perspekt\u00edva MediPharm)<\/h3><p>MediPharm pristupuje k v\u00fdvoju nukleozidov\u00fdch a nukleotidov\u00fdch anal\u00f3gov zos\u00faladen\u00edm v\u00fdberu chemick\u00fdch a chemoenzymatick\u00fdch ciest s n\u00e1sledn\u00fdmi po\u017eiadavkami na formul\u00e1ciu a GMP v\u00fdrobu. V\u00fdvoj cesty sa zameriava na integr\u00e1ciu selekt\u00edvnych enzymatick\u00fdch krokov tam, kde je to v\u00fdhodn\u00e9, optimaliz\u00e1ciu teleskopick\u00fdch sekvenci\u00ed na minimaliz\u00e1ciu manipul\u00e1cie s rozp\u00fa\u0161\u0165adlami a medziproduktmi a implement\u00e1ciu pokro\u010dil\u00fdch kontrol kry\u0161taliz\u00e1cie a in\u017einierstva \u010dast\u00edc na zabezpe\u010denie konzistentnej formy pevnej f\u00e1zy a rozp\u00fa\u0161\u0165ania. V\u00fdvoj formul\u00e1cie zd\u00f4raz\u0148uje pr\u00edstupy, ktor\u00e9 stabilizuj\u00fa labiln\u00e9 akt\u00edvne l\u00e1tky a zachov\u00e1vaj\u00fa biologick\u00fa dostupnos\u0165 \u2013 pri\u010dom pevn\u00e9 disperzie, lipidov\u00e9 syst\u00e9my a lyofiliz\u00e1cia s\u00fa k\u013e\u00fa\u010dov\u00fdmi mo\u017enos\u0165ami \u2013 zatia\u013e \u010do analytick\u00fd v\u00fdvoj stanovuje validovan\u00e9 testy indikuj\u00face stabilitu a ortogon\u00e1lne pracovn\u00e9 postupy identifik\u00e1cie ne\u010dist\u00f4t. GMP v\u00fdroba sa zameriava na validovan\u00fa kvalifik\u00e1ciu v\u00fdkonu procesu, kontrolovan\u00e9 prostredia pre steriln\u00fa manipul\u00e1ciu tam, kde je to potrebn\u00e9, komplexn\u00e9 programy monitorovania stability a dokument\u00e1ciu CMC pripraven\u00fa pre dossier, prisp\u00f4soben\u00fa pre regula\u010dn\u00e9 zapojenie v E\u00da a porovnate\u013en\u00fdch jurisdikci\u00e1ch.   <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-54ff33b elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"54ff33b\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bbae0fb elementor-widget elementor-widget-text-editor\" data-id=\"bbae0fb\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>Z\u00e1ver a odpor\u00fa\u010dan\u00e9 zameranie v\u00fdvoja<\/h3><p>Nukleozidov\u00e9 anal\u00f3gy pon\u00fakaj\u00fa siln\u00e9 a selekt\u00edvne mechanizmy \u00fa\u010dinku, ale vy\u017eaduj\u00fa integrovan\u00e9 rie\u0161enia, ktor\u00e9 zah\u0155\u0148aj\u00fa stereoselekt\u00edvnu synt\u00e9zu, kontrolu pevnej f\u00e1zy, vedu o formul\u00e1cii a d\u00f4kladn\u00fa analytick\u00fa charakteriz\u00e1ciu. Efekt\u00edvny pokrok od objavu k GMP dod\u00e1vke profituje z v\u010dasnej defin\u00edcie profilu cie\u013eov\u00e9ho produktu, v\u010dasn\u00e9ho vyhodnotenia chemoenzymatick\u00fdch mo\u017enost\u00ed, implement\u00e1cie ortogon\u00e1lnych a stabilitu indikuj\u00facich analytick\u00fdch met\u00f3d, proakt\u00edvnej kontroly polymorfizmu a atrib\u00fatov \u010dast\u00edc a pr\u00edpravy dossieru ne\u010dist\u00f4t a stability zalo\u017een\u00e9ho na riziku pre regula\u010dn\u00fa interakciu. Integrovan\u00fd v\u00fdvojov\u00fd a v\u00fdrobn\u00fd partner s kapacitami v biokatal\u00fdze, kry\u0161taliza\u010dnom in\u017einierstve, formul\u00e1cii a validovan\u00fdch analytick\u00fdch met\u00f3dach podstatne zni\u017euje technick\u00e9 riziko a ur\u00fdch\u013euje regula\u010dn\u00fa pripravenos\u0165.  <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-77cb046 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"77cb046\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-29953e7 elementor-widget elementor-widget-text-editor\" data-id=\"29953e7\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>Perspekt\u00edva MediPharm<\/h3><p>MediPharm pova\u017euje nukleozidov\u00e9 a nukleotidov\u00e9 anal\u00f3gy za strategick\u00fa oblas\u0165 rastu, ktor\u00e1 sp\u00e1ja jej k\u013e\u00fa\u010dov\u00e9 siln\u00e9 str\u00e1nky. MediPharm m\u00e1 rozsiahle sk\u00fasenosti s v\u00fdrobou, formul\u00e1ciou a lyofiliz\u00e1ciou acykloviru. Tieto praktick\u00e9 sk\u00fasenosti naprie\u010d v\u00fdvojov\u00fdmi f\u00e1zami posil\u0148uj\u00fa schopnos\u0165 MediPharm dod\u00e1va\u0165 vysokokvalitn\u00e9 antiv\u00edrusov\u00e9 formul\u00e1cie v podmienkach GMP. Prostredn\u00edctvom neust\u00e1lych invest\u00edci\u00ed do v\u00fdskumu a v\u00fdvoja, analytick\u00fdch kapac\u00edt a pokro\u010dil\u00fdch v\u00fdrobn\u00fdch technol\u00f3gi\u00ed sa MediPharm sna\u017e\u00ed roz\u0161\u00edri\u0165 svoju \u00falohu d\u00f4veryhodn\u00e9ho partnera pre v\u00fdrobu nukleozidov\u00fdch anal\u00f3gov.   <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bdd0e98 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"bdd0e98\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-743ab794 elementor-widget elementor-widget-spacer\" data-id=\"743ab794\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-26cd52d5 elementor-widget elementor-widget-post-info\" data-id=\"26cd52d5\" data-element_type=\"widget\" data-widget_type=\"post-info.default\">\n\t\t\t\t\t\t\t<ul class=\"elementor-inline-items elementor-icon-list-items elementor-post-info\">\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item elementor-repeater-item-947b1e1 elementor-inline-item\" itemprop=\"datePublished\">\n\t\t\t\t\t\t<a href=\"https:\/\/medi-pharm.sk\/sk\/2025\/09\/15\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-calendar\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M12 192h424c6.6 0 12 5.4 12 12v260c0 26.5-21.5 48-48 48H48c-26.5 0-48-21.5-48-48V204c0-6.6 5.4-12 12-12zm436-44v-36c0-26.5-21.5-48-48-48h-48V12c0-6.6-5.4-12-12-12h-40c-6.6 0-12 5.4-12 12v52H160V12c0-6.6-5.4-12-12-12h-40c-6.6 0-12 5.4-12 12v52H48C21.5 64 0 85.5 0 112v36c0 6.6 5.4 12 12 12h424c6.6 0 12-5.4 12-12z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text elementor-post-info__item elementor-post-info__item--type-date\">\n\t\t\t\t\t\t\t\t\t\t<time>15 septembra, 2025<\/time>\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t<\/li>\n\t\t\t\t<li class=\"elementor-icon-list-item elementor-repeater-item-f958ce5 elementor-inline-item\">\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-far-clock\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M256 8C119 8 8 119 8 256s111 248 248 248 248-111 248-248S393 8 256 8zm0 448c-110.5 0-200-89.5-200-200S145.5 56 256 56s200 89.5 200 200-89.5 200-200 200zm61.8-104.4l-84.9-61.7c-3.1-2.3-4.9-5.9-4.9-9.7V116c0-6.6 5.4-12 12-12h32c6.6 0 12 5.4 12 12v141.7l66.8 48.6c5.4 3.9 6.5 11.4 2.6 16.8L334.6 349c-3.9 5.3-11.4 6.5-16.8 2.6z\"><\/path><\/svg>\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text elementor-post-info__item elementor-post-info__item--type-time\">\n\t\t\t\t\t\t\t\t\t\t<time>12:37 pm<\/time>\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Vedeck\u00e9 pozadie a terapeutick\u00fd kontext Nukleozidy, pozost\u00e1vaj\u00face z dus\u00edkatej b\u00e1zy kovalentne viazanej na rib\u00f3zu alebo deoxyrib\u00f3zu, s\u00fa z\u00e1kladn\u00fdmi prekurzormi pre biosynt\u00e9zu nukleov\u00fdch kysel\u00edn a tvoria chemick\u00e9 jadro oligonukleotidov\u00fdch monom\u00e9rov pou\u017e\u00edvan\u00fdch pri synt\u00e9ze na pevnej f\u00e1ze. Chemicky vyr\u00e1ban\u00e9 DNA fosforamidity typicky obsahuj\u00fa chr\u00e1nen\u00fa 5\u2032\u2011hydroxylov\u00fa skupinu (5\u2032\u2011DMT) a 3\u2032\u2011fosforamidit nes\u00faci kyanoetylov\u00e9 a diizopropylam\u00ednov\u00e9 \u010dasti, zatia\u013e \u010do RNA [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1493,"comment_status":"closed","ping_status":"open","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-1392","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-sk"],"_links":{"self":[{"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/posts\/1392","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/comments?post=1392"}],"version-history":[{"count":4,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/posts\/1392\/revisions"}],"predecessor-version":[{"id":1595,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/posts\/1392\/revisions\/1595"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/media\/1493"}],"wp:attachment":[{"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/media?parent=1392"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/categories?post=1392"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medi-pharm.sk\/sk\/wp-json\/wp\/v2\/tags?post=1392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}